a Phase II Study of Lapatinib plus Topotecan or Lapatini

Project: Research project

Project Details

Description

a Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer
StatusFinished
Effective start/end date1/12/079/15/09

Funding

  • GlaxoSmithKline

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.